Science Explorer Back to mapMap
Discussion
Company · Seongnam-si · South Korea

Qurient (South Korea)

qurient.comROR OpenAlex
Research works
29
▲ 27% vs 2018-21
Citations
263
9.0 per fractional work
Top-10% rate
11.9%
all institutions 10.0%
Open access
20%
world 40%
International
16%
world 18%
Qurient (South Korea)

Not ranked overall: Qurient (South Korea) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Qurient (South Korea) work in?

In all years, 35% of research at Qurient (South Korea) is in Health Sciences, 29% in Life Sciences. Its largest fields are Medicine (34%), Immunology and Microbiology (16%), Engineering (14%). It does 1.5× the world's share of Life Sciences.

Health Sciences: 10 fractional works · 35.3% of its workMedicine: 10 fractional works · 34.4% of its workPulmonary and Respiratory Medicine: 2 fractional works · 7.5% of its workOncology: 2 fractional works · 7.4% of its workComplementary and alternative medicine: 1 fractional works · 4.5% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 4.0% of its workInfectious Diseases: 1 fractional works · 3.3% of its workEpidemiology: 1 fractional works · 2.4% of its workSurgery: 0 fractional works · 1.7% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 1.1% of its workPathology and Forensic Medicine: 0 fractional works · 1.1% of its workDermatology: 0 fractional works · 0.4% of its workHematology: 0 fractional works · 0.4% of its workPhysiology: 0 fractional works · 0.2% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.2% of its workHealth Professions: 0 fractional works · 0.6% of its workGeneral Health Professions: 0 fractional works · 0.6% of its workVeterinary: 0 fractional works · 0.4% of its workSmall Animals: 0 fractional works · 0.4% of its workLife Sciences: 8 fractional works · 28.5% of its workImmunology and Microbiology: 5 fractional works · 16.0% of its workImmunology: 5 fractional works · 15.7% of its workVirology: 0 fractional works · 0.2% of its workBiochemistry, Genetics and Molecular Biology: 3 fractional works · 10.1% of its workMolecular Biology: 2 fractional works · 7.7% of its workBiotechnology: 0 fractional works · 1.1% of its workCancer Research: 0 fractional works · 0.6% of its workPhysiology: 0 fractional works · 0.4% of its workCell Biology: 0 fractional works · 0.3% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 2.5% of its workPharmaceutical Science: 1 fractional works · 1.7% of its workPharmacology: 0 fractional works · 0.8% of its workPhysical Sciences: 7 fractional works · 24.8% of its workEngineering: 4 fractional works · 13.7% of its workElectrical and Electronic Engineering: 2 fractional works · 5.1% of its workCivil and Structural Engineering: 1 fractional works · 3.4% of its workMechanics of Materials: 0 fractional works · 1.7% of its workBuilding and Construction: 0 fractional works · 1.1% of its workControl and Systems Engineering: 0 fractional works · 1.1% of its workBiomedical Engineering: 0 fractional works · 0.6% of its workAerospace Engineering: 0 fractional works · 0.6% of its workEnvironmental Science: 1 fractional works · 4.2% of its workManagement, Monitoring, Policy and Law: 0 fractional works · 1.6% of its workEcology: 0 fractional works · 1.3% of its workWater Science and Technology: 0 fractional works · 1.1% of its workSmaller subfields together: 0 fractional works · 0.2% of its workComputer Science: 1 fractional works · 2.3% of its workComputer Vision and Pattern Recognition: 0 fractional works · 1.1% of its workComputer Networks and Communications: 0 fractional works · 0.6% of its workComputational Theory and Mathematics: 0 fractional works · 0.3% of its workHardware and Architecture: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workEarth and Planetary Sciences: 1 fractional works · 2.3% of its workAtmospheric Science: 1 fractional works · 2.3% of its workPhysics and Astronomy: 0 fractional works · 1.1% of its workAtomic and Molecular Physics, and Optics: 0 fractional works · 1.1% of its workChemistry: 0 fractional works · 0.6% of its workOrganic Chemistry: 0 fractional works · 0.6% of its workMaterials Science: 0 fractional works · 0.6% of its workElectronic, Optical and Magnetic Materials: 0 fractional works · 0.6% of its workSocial Sciences: 3 fractional works · 11.4% of its workSocial Sciences: 2 fractional works · 5.7% of its workEducation: 2 fractional works · 5.7% of its workEconomics, Econometrics and Finance: 1 fractional works · 3.4% of its workEconomics and Econometrics: 1 fractional works · 3.4% of its workBusiness, Management and Accounting: 1 fractional works · 2.3% of its workManagement Information Systems: 0 fractional works · 1.1% of its workManagement of Technology and Innovation: 0 fractional works · 1.1% of its workSmaller subfields together: 0 fractional works · 0.0% of its workALL ITS WORKQurient (SouthKorea)29fractional works, all years
Life Sciences29%Physical Sciences25%Health Sciences35%Social Sciences11%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 16 fields, with their numbers
    1. Medicine1034.4%
    2. Health Professions00.6%
    3. Veterinary00.4%
    1. Immunology and Microbiology516.0%
    2. Biochemistry, Genetics and Molecular Biology310.1%
    3. Pharmacology, Toxicology and Pharmaceutics12.5%
    1. Engineering413.7%
    2. Environmental Science14.2%
    3. Computer Science12.3%
    4. Earth and Planetary Sciences12.3%
    5. Physics and Astronomy01.1%
    6. Chemistry00.6%
    7. Materials Science00.6%
    1. Social Sciences25.7%
    2. Economics, Econometrics and Finance13.4%
    3. Business, Management and Accounting12.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 4.22× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 20.74× its world share, 2 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 18.80× its world share, 1 worksPharmacology, Toxico…Chemistry: 1.11× its world share, 0 worksChemistryComputer Science: 0.56× its world share, 0 worksComputer ScienceEngineering: 0.48× its world share, 1 worksEngineeringHealth Professions: 0.19× its world share, 0 worksHealth ProfessionsMedicine: 1.88× its world share, 4 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 20.7×. Every wedge is a field page.

All 8 fields, with their numbers
  1. Immunology and Microbiology20.74×2 works
  2. Pharmacology, Toxicology and Pharmaceutics18.80×1 works
  3. Biochemistry, Genetics and Molecular Biology4.22×2 works
  4. Medicine1.88×4 works
  5. Chemistry1.11×0 works
  6. Computer Science0.56×0 works
  7. Engineering0.48×1 works
  8. Health Professions0.19×0 works

Who are the top researchers at Qurient (South Korea)?

Ranked on the quality score, Jaeseung C. Kim, Kiyean Nam and Hwankyu Kang lead among researchers whose main affiliation is Qurient (South Korea).

  1. 1 Jaeseung C. Kim South Korea · #790,761 worldwide 4.8k citations · 75 works
  2. 2 Kiyean Nam South Korea · #1,177,926 worldwide 1.2k citations · 43 works
  3. 3 Hwankyu Kang South Korea · #1,825,362 worldwide 894 citations · 20 works
  4. 4 Jeongjun Kim South Korea · #1,905,936 worldwide 509 citations · 33 works
  5. 5 Yeejin Jeon South Korea · #2,504,311 worldwide 106 citations · 18 works
  6. 6 Jiye Ahn South Korea · #3,396,428 worldwide 180 citations · 17 works
All ranked researchers at Qurient (South Korea)

What are the most cited papers from Qurient (South Korea)?

The most cited paper from Qurient (South Korea) is "Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis" (Kévin Pethe et al., 2013), with 621 citations. Next come "A Comparative Study of Modern Inference Techniques for Discrete Energy Minimization Problems" (202) and "Lead Optimization of a Novel Series of Imidazo[1,2-a]pyridine Amides Leading to a Clinical Candidate (Q203) as a Multi- and Extensively-Drug-Resistant Anti-tuberculosis Agent" (178).

Most cited papers
#PaperReleasedCitations
1 Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis Kévin Pethe et al. · Nature Medicine Open access 4 Aug 2013 621
2 A Comparative Study of Modern Inference Techniques for Discrete Energy Minimization Problems Jörg Hendrik Kappes, Bjoern Andres, Fred A. Hamprecht et al. Conference paper Jun 2013 202
3 Lead Optimization of a Novel Series of Imidazo[1,2-a]pyridine Amides Leading to a Clinical Candidate (Q203) as a Multi- and Extensively-Drug-Resistant Anti-tuberculosis Agent Sun‐Hee Kang et al. · Journal of Medicinal Chemistry Open access 28 May 2014 178
4 Telacebec (Q203), a New Antituberculosis Agent Veronique R. De Jager, Rodney Dawson, Christo van Niekerk et al. · New England Journal of Medicine Open access 25 Mar 2020 142
5 A locally funded Puerto Rican parrot (Amazona vittata) genome sequencing project increases avian data and advances young researcher education Tarás K. Oleksyk, Jean‐François Pombert, Daniel Siu et al. · GigaScience Open access 28 Sep 2012 51
All 29 most cited papers, with filters and sorting

Which keywords describe research at Qurient (South Korea)?

By fractional works in all years, weighted toward what it does more of than the world: apoptotic cells, CD47, Breast Cancer, Metastatic Breast Cancer, CDK4/6 Inhibitors, Palbociclib, Cancer Therapy and Chemotherapy.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 35 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 35 words, with their numbers
  1. CD472▲ 561×1 topic
  2. apoptotic cells2▲ 561×1 topic
  3. Breast Cancer2▲ 25×2 topics
  4. Inflammation2▲ 2.9×5 topics
  5. Metastatic Breast Cancer2▲ 101×2 topics
  6. CDK4/6 Inhibitors2▲ 409×1 topic
  7. Palbociclib2▲ 409×1 topic
  8. Cancer Therapy2▲ 9.6×5 topics
  9. Remote Sensing2▲ 5.2×4 topics
  10. Cancer2▲ 4.0×3 topics
  11. Chemotherapy2▲ 7.9×5 topics
  12. Epidemiology1▲ 1.22×5 topics
  13. Treatment1▲ 3.7×5 topics
  14. Activation1▲ 128×1 topic
  15. Artificial Intelligence1▲ 5.5×2 topics
  16. Diagnosis1▲ 4.3×3 topics
  17. Macrophage1▲ 80×1 topic
  18. Atherosclerosis1▲ 11×3 topics
  19. Cancer Progression1▲ 17×2 topics
  20. Deep Learning1▲ 1.88×2 topics
  21. Immune Response1▲ 6.8×4 topics
  22. Pharmacokinetics1▲ 14×3 topics
  23. Antioxidant1▲ 5.8×2 topics
  24. Regulation1▲ 6.2×2 topics
  25. Asset Pricing1▲ 25×1 topic
  26. Cell Cycle1▲ 61×1 topic
  27. DNA1▲ 109×1 topic
  28. Ginkgo Biloba1▲ 381×1 topic
  29. Ideological Education1▲ 91×1 topic
  30. Monetary Equilibrium1▲ 70×1 topic
  31. Neuroprotective1▲ 28×1 topic
  32. Political Education1▲ 91×1 topic
  33. Targeted Therapy1▲ 16×5 topics
  34. Topoisomerases1▲ 109×1 topic
  35. p531▲ 80×1 topic

Which research topics does Qurient (South Korea) publish most on?

By volume in 2022-now: RNA modifications and cancer, Phagocytosis and Immune Regulation, Immune cells in cancer and Cancer therapeutics and mechanisms.

RNA modifications and cancer: 1 fractional worksPhagocytosis and Immune Regulation: 1 fractional worksImmune cells in cancer1Immune cells in cancer: 1 fractional worksCancer therapeutics and …0Cancer therapeutics and mechanisms: 0 fractional worksCancer-related Molecular Pathways: 0 fractional worksUbiquitin and proteasome pathways: 0 fractional worksAdvancements in Transder…0Advancements in Transdermal Drug Delivery: 0 fractional worksLung Cancer Research Studies: 0 fractional worksRadiopharmaceutical Chemistry and Applications: 0 fractional worksImmune Cell Function and Interaction: 0 fractional works
Molecular BiologyImmunologyOncologyPharmaceutical Science1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 RNA modifications and cancer Molecular Biology 1 works
  2. 2 Phagocytosis and Immune Regulation Immunology 1 works
  3. 3 Immune cells in cancer Immunology 1 works
  4. 4 Cancer therapeutics and mechanisms Molecular Biology 0 works
  5. 5 Cancer-related Molecular Pathways Oncology 0 works
  6. 6 Ubiquitin and proteasome pathways Molecular Biology 0 works
  7. 7 Advancements in Transdermal Drug Delivery Pharmaceutical Science 0 works
  8. 8 Lung Cancer Research Studies Oncology 0 works
  9. 9 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 0 works
  10. 10 Immune Cell Function and Interaction Immunology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available19.5%not open80.5%

World: 40% of research is openly available.

with international co-authors16.0%domestic only84.0%

World: 18% is written across borders.

How has Qurient (South Korea)'s research output changed?

Output in 2022-2025 was 27% higher than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Qurient (South Korea) as a percentage of every work published that year, 0.000029% in 2024.

still counting0.00010%0.00020%Qurient (South Korea)0.000049% in 202520102020

Fractional works of Qurient (South Korea) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Seongnam-si

All research institutions in Seongnam-si

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Qurient (South Korea). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.